Technical Analysis for MYO - Myomo Inc.

Grade Last Price % Change Price Change
grade F 3.74 -4.59% -0.18
MYO closed down 4.59 percent on Wednesday, April 25, 2018, on 71 percent of normal volume. The stock fell below its 50 day moving average, damaging its intermediate-term outlook by crossing under that important trendline.

Trend Table & Recent Alerts
ADX Long-Term Intermediate-Term Short-Term
Weak or Absent Down Down Up
See historical MYO trend table...

Date Alert Name Type % Chg
Apr 25 Fell Below 50 DMA Bearish 0.00%
Apr 25 MACD Bullish Centerline Cross Bullish 0.00%
Apr 25 Upper Bollinger Band Walk Strength 0.00%
Apr 25 Inside Day Range Contraction 0.00%
Apr 25 Wide Bands Range Expansion 0.00%
Apr 25 Upper Bollinger Band Touch Strength 0.00%
Apr 24 Crossed Above 50 DMA Bullish -4.59%
Apr 24 180 Bullish Setup Bullish Swing Setup -4.59%
Apr 24 Upper Bollinger Band Walk Strength -4.59%
Apr 24 Wide Bands Range Expansion -4.59%

Older signals for MYO ...

Free Daily (Stock) Chart Reading

Let us help you stay on top of your investments. We will alert you to important technical developments on your portfolio & watchlist.
Configure default chart indicators
Basic chart:

Profile
Myomo, Inc. is a commercial stage medical robotics Company that offers expanded mobility for those suffering from neurological disorders and upper limb paralysis. Based on patented technology developed at MIT and the Company, Myomo develops and markets the MyoPro® product line of lightweight, non-invasive, powered arm braces to restore function in the paralyzed or weakened arms and hands of individuals that have suffered a stroke, spinal cord or nerve injury such as brachial plexus injury, or other neuromuscular disability such as amyotrophic lateral sclerosis (ALS) or multiple sclerosis (MS). It is provided through clinical relationships with VA medical centers, leading rehabilitation hospitals, and Orthotics and Prosthetics (“O&P”) practices. Several hundred have been successfully used by patients. It is the only device that, sensing a patient’s own neurological signals through non-invasive sensors on the arm, can restore their ability to use their arms and hands so that they can return to work, live independently and reduce their cost of care. Myomo is headquartered in Cambridge, Massachusetts, with sales and clinical professionals across the U.S. For more information, please visit www.myomo.com.
Is MYO a Buy, Sell or Hold?
Indicator Bull Case Neutral / Hold Bear Case
50 DMA
200 DMA
ADX Trend
Oversold / Overbought
Relative Strength
Summary: Counts: 0 bullish, 3 bearish and 2 neutral indicators. You may wish to incorporate that into your trading strategies.
Indicators
Indicator Value
52 Week High 23.2
52 Week Low 2.07
Average Volume 651,574
200-Day Moving Average 5.0625
50-Day Moving Average 3.7912
20-Day Moving Average 3.368
10-Day Moving Average 3.53
Average True Range 0.333
ADX 20.03
+DI 28.63
-DI 14.32
Chandelier Exit (Long, 3 ATRs ) 3.301
Chandelier Exit (Short, 3 ATRs ) 3.799
Upper Bollinger Band 3.9453
Lower Bollinger Band 2.7907
Percent B (%b) 0.82
BandWidth 34.281473
MACD Line 0.009
MACD Signal Line -0.0888
MACD Histogram 0.0978
Fundamentals Value
Market Cap 22.77 Million
Num Shares 6.09 Million
EPS -8.54
Price-to-Earnings (P/E) Ratio -0.44
Price-to-Sales 14.12
Price-to-Book 4.12
PEG Ratio 0.00
Dividend 0.00
Dividend Yield 0.00%
Pivot Point Level Traditional / Classic Fibonacci Demark Woodie Camarilla
Resistance 4 (R4) 4.22
Resistance 3 (R3) 4.25 4.13 4.14
Resistance 2 (R2) 4.13 4.00 4.11 4.11
Resistance 1 (R1) 3.93 3.93 3.87 3.90 4.09
Pivot Point 3.81 3.81 3.78 3.79 3.81
Support 1 (S1) 3.61 3.68 3.55 3.58 3.39
Support 2 (S2) 3.49 3.61 3.47 3.37
Support 3 (S3) 3.29 3.49 3.34
Support 4 (S4) 3.26